Effect of Intranasal Breast Milk Administration in Preterm Infants
: Effect of Intranasal Breast Milk Administration on Cerebral Oxygenation, Vital Signs and Transition Time to Full Oral Feeding in Preterm Babies: Randomized Controlled Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of the study was to investigate the effect of intranasal breast milk administration on cerebral oxygenation level, vital signs and time to full oral feeding in preterm infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2024
CompletedStudy Start
First participant enrolled
June 30, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedNovember 26, 2024
November 1, 2024
1.2 years
May 21, 2024
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Infant Information Form
The form developed by the researchers in line with the literature includes the identifying information of the preterm infant (gender, date of birth, gestational week at birth, mode of delivery, APGAR score, birth weight, postmenstrual age)
First measurement-First day of hospitalization
Physiologic Parameter Follow-up Form-Cerebral rSO2
Cerebral rSO2 in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.
First measurement- 5 minutes before the intervention (T0)
Physiologic Parameter Follow-up Form-Oxygen saturation (sPO2)
Oxygen saturation (sPO2) in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.
First measurement- 5 minutes before the intervention (T0)
Physiologic Parameter Follow-up Form-Heart Rate (HR)
Heart rate in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.
First measurement- 5 minutes before the intervention (T0)
Physiologic Parameter Follow-up Form-Respiratory rate
Respiratory rate in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.
First measurement- 5 minutes before the intervention (T0)
Nutrition Follow-up Form-intranasal breast milk content
Intranasal breast milk content (fresh/thawed) in the Nutrition Follow-up Form will be recorded before the intervention.
First measurement- intranasal breast milk content
Secondary Outcomes (17)
Physiologic Parameter Follow-up Form -Cerebral rSO2
Second measurement- 5. minutes after the intervention (T1)
Physiologic Parameter Follow-up Form -Cerebral rSO2
Second measurement- 15. minutes after the intervention (T1)
Physiologic Parameter Follow-up Form -Cerebral rSO2
Second measurement- 30. minutes after the intervention (T1)
Physiologic Parameter Follow-up Form -Oxygen saturation (sPO2)
Second measurement- 5. minutes after the intervention (T1)
Physiologic Parameter Follow-up Form -Oxygen saturation (sPO2)
Second measurement- 15. minutes after the intervention (T1)
- +12 more secondary outcomes
Study Arms (2)
Intranasal Breast Milk Group
EXPERIMENTALPreterm infants (28-37 gestation week) in the intervention group will receive 0.2 ml of breast milk intranasally three times a day for three days.
Control Group
NO INTERVENTIONPreterm newborns in the control group will not receive any intervention.
Interventions
The information in the "Physiologic Parameter Follow-up Form" will be recorded by the investigator just 5 minutes before the intervention. The researcher will drip 0.2 ml of breast milk at room temperature (approximately 22 °C) into the nose of the infant lying in the supine position, 0.1 ml in the right nose-0.1 ml in the left nose. 5 minutes after the intervention (T1), 15 minutes after the intervention (T2) and 30 minutes after the intervention (T3), the data in the "Physiologic Parameter Follow-up Form" will be recorded by the researcher. After intranasal breast milk administration, the baby will be fed by the neonatal nurse as in routine practice. The implementation of the intervention in the study will last for three days and this process will be repeated three times every day (09.00, 12.00 and 15.00).
Eligibility Criteria
You may qualify if:
- Birth weight \>1000 gr,
- APGAR score \>7 at 5 minutes after birth,
- Availability of breast milk,
- No medical diagnosis affecting cerebral oxygenation (intraventricular hemorrhage, cardiovascular and neurological disorders, anemia),
- No congenital anomalies or chromosomal abnormalities,
- No congenital anomaly (such as cleft palate) affecting nasal patency.
You may not qualify if:
- Being able to feed orally in all feedings
- Being fed entirely on formula milk,
- Administration of medication via the nasal route,
- Being intubated or receiving continuous positive air pressure (CPAP) support,
- Maternal substance abuse, alcohol abuse, HIV infection, untreated active tuberculosis, chemotherapy or radiotherapy treatment,
- The mother has mastitis, breast trauma, abscesses or is taking any medication that passes into the milk,
- The mother does not want to express milk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Selcuk University
Konya, Turkey (Türkiye)
Related Publications (5)
Keller T, Korber F, Oberthuer A, Schafmeyer L, Mehler K, Kuhr K, Kribs A. Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation. Eur J Pediatr. 2019 Feb;178(2):199-206. doi: 10.1007/s00431-018-3279-7. Epub 2018 Nov 1.
PMID: 30386923BACKGROUNDHoban R, Gallipoli A, Signorile M, Mander P, Gauthier-Fisher A, Librach C, Wilson D, Unger S. Feasibility of intranasal human milk as stem cell therapy in preterm infants with intraventricular hemorrhage. J Perinatol. 2024 Nov;44(11):1652-1657. doi: 10.1038/s41372-024-01982-8. Epub 2024 Apr 30.
PMID: 38688998BACKGROUNDMuelbert M, Alexander T, Pook C, Jiang Y, Harding JE, Bloomfield FH. Cortical Oxygenation Changes during Gastric Tube Feeding in Moderate- and Late-Preterm Babies: A NIRS Study. Nutrients. 2021 Jan 25;13(2):350. doi: 10.3390/nu13020350.
PMID: 33503882BACKGROUNDYucel A, Kucukoglu S, Soylu H. The Effect of Breast Milk Odor on Feeding Cues, Transition Time to Oral Feeding, and Abdominal Perfusion in Premature Newborns: A Randomised Controlled Trial. Biol Res Nurs. 2024 Jan;26(1):160-175. doi: 10.1177/10998004231200784. Epub 2023 Sep 8.
PMID: 37682253BACKGROUNDYucel A, Kucukoglu S, Konak M. The Effect of Intranasal Breast Milk Administration on Cerebral Oxygenation, Vital Signs and Time to Full Oral Feeding in Preterm Infants: a Randomised Controlled Study Protocol. Nurs Crit Care. 2026 Jan;31(1):e70262. doi: 10.1111/nicc.70262.
PMID: 41542903DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sibel Kucukoglu, Prof
Selcuk University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
May 21, 2024
First Posted
November 26, 2024
Study Start
June 30, 2024
Primary Completion
September 15, 2025
Study Completion
December 30, 2025
Last Updated
November 26, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
It will be shared after the article is published.